"Designing Growth Strategies is in our DNA"

Renal Therapeutics Market Size, Share And Global Trend By Application (Chronic kidney disease, Diabetes, Kidney stone disease, Kidney failure, Others), By Drug Class (Angiotensin-II receptor blockers, ACE Inhibitors, Calcium channel blockers, Beta-blockers, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And Geography Forecast Till 2021-2028

In April 2019, Merck Sharp & Dohme Corp. received U.S Food and Drug Administration approval for the drug KEYTRUDA (pembrolizumab) for the treatment of renal cell carc... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Upcoming | Report ID: FBI100583 | Status : Upcoming

 

Request PDF Brochure

Refresh Button
Renal Therapeutics Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2014-2018
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X